Reteplase (r-PA):

Author： Bode C.   Kohler B.   Moser M.   Schmittner M.   Smalling R.W.   Strasser R.H.  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.6, Iss.8, 1997-08, pp. : 1099-1104

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mixed news with reteplase + abciximab in MI

By  

Inpharma, Vol. 1, Iss. 1293, 2001-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

Reteplase: Retro-orbital haemorrhage: case report

By  

Reactions Weekly, Vol. 1, Iss. 1173, 2007-01 ,pp. : 23-23

Adis International

Access to resources Recommend Favorite

Reteplase + abciximab: alternative reperfusion strategy for MI

By  

Inpharma, Vol. 1, Iss. 1364, 2002-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Current Clinical Use of Reteplase for Thrombolysis: A Pharmacokinetic-Pharmacodynamic Perspective

By Martin U.  

Clinical Pharmacokinetics, Vol. 36, Iss. 4, 1999-04 ,pp. : 265-276

Adis International

Access to resources Recommend Favorite

Reteplase: A Review of its Use in the Management of Thrombotic Occlusive Disorders

By Simpson Dene  

American Journal of Cardiovascular Drugs, Vol. 6, Iss. 4, 2006-01 ,pp. : 265-285

Adis International

Access to resources Recommend Favorite